• Neurocrine Biosciences average return on assets for 2023 was 6.72, a 90.37% increase from 2022.
• Neurocrine Biosciences average return on assets for 2022 was 3.53, a 80.7% increase from 2021.
• Neurocrine Biosciences average return on assets for 2021 was 18.29, a 16.57% decline from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.